June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Ophthalmic involvement in PHACES syndrome: Prevalence, spectrum of anomalies and outcomes
Author Affiliations & Notes
  • Sameh Soliman
    Ophthalmology, The Hospital for Sick Children, Toronto, Ontario, Canada
    Ophthalmology, Alexandria University Faculty of Medicine, Alexandria, Egypt
  • Michael Wan
    Ophthalmology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Alexandra Pennal
    Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Elena Pope
    Dermatology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Kamiar Mireskandari
    Ophthalmology, The Hospital for Sick Children, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Sameh Soliman, None; Michael Wan, None; Alexandra Pennal, None; Elena Pope, None; Kamiar Mireskandari, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3513. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sameh Soliman, Michael Wan, Alexandra Pennal, Elena Pope, Kamiar Mireskandari; Ophthalmic involvement in PHACES syndrome: Prevalence, spectrum of anomalies and outcomes. Invest. Ophthalmol. Vis. Sci. 2021;62(8):3513.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : PHACES Syndrome includes Posterior fossa malformations, infantile Hemangiomas (95% facial, IFH) with Arterial, Cardiac, Eye and Sternal anomalies. Data on ophthalmic involvement are limited with variable prevalence. We aim to present a large cohort of patients with PHACES highlighting prevalence, spectrum of anomalies and outcomes of ophthalmic involvement.

Methods : A retrospective, non-comparative, single-institutional observational case series was performed. All patients with documented PHACES syndrome diagnosed and managed between 2000-2019 at a single tertiary referral center were reviewed. Data collected included gender, age, diagnostic criteria (Major and minor), IFH distribution, ocular presentation, ophthalmic/visual interventions, follow-up and visual acuity. Primary outcome measures were the frequency and spectrum of ocular involvement. The secondary outcomes were final visual acuity (Poor visual outcome was defined as final visual acuity worse than 20/200), long-term ocular sequelae and need for surgical intervention. Simple descriptive statistics calculating frequencies and mean was utilized.

Results : Forty-three infants [33 females (77%), mean presenting age 8 weeks] were reviewed. Six infants (14%) had primary congenital ocular anomalies. These included diagnostic criteria [optic nerve anomalies (6), anterior segment dysgenesis (1) and retinal vascular anomalies (1)], and non-diagnostic abnormalities [persistent pupillary membrane (2)]. Twenty-nine infants (67%) had secondary ophthalmic involvement due to IFH [ptosis (20 mild, 9 severe), proptosis (9), strabismus (6)]. After mean follow-up 8.7 years post-IFH diagnosis, 8/29 children required surgical intervention [Strabismus (6), entropion (2), ptosis (2), optical iridectomy (1)], all with orbital/conjunctival hemangioma (p=0.03). Final visual acuity ranged between 20/20 to 20/80 in 26/29 and <20/200 in 3/29 children (all had optic nerve anomalies). One child died from associated cardiac compromise.

Conclusions : Identifying common ophthalmic associations in PHACES syndrome was impactful for both diagnostic and vision rehabilitation purposes. Monitoring for and management of periocular IFH complications showed promising visual acuity outcomes.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×